Data as of Apr 17
| -0.13 / -0.38%|
The 31 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 36.94, with a high estimate of 42.16 and a low estimate of 27.00. The median estimate represents a +8.65% increase from the last price of 34.00.
The current consensus among 35 polled investment analysts is to Hold stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.